Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.75B |
| 2 |
Microsoft
MSFT
|
+$1.78B |
| 3 |
Fortive
FTV
|
+$1.26B |
| 4 |
AGN
Allergan plc
AGN
|
+$797M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.98B |
| 2 |
Danaher
DHR
|
+$1.61B |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$1.56B |
| 4 |
McDonald's
MCD
|
+$972M |
| 5 |
CELG
Celgene Corp
CELG
|
+$940M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.65% |
| 2 | Technology | 15.07% |
| 3 | Financials | 13.7% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEST
2301
DELISTED
Destination Maternity Corporation
DEST
| $1.96M | ﹤0.01% |
276,250
-16,200
| -6% | -$94.6K |
|
2302
Four Corners Property Trust
FCPT
$2.78B
| $1.95M | ﹤0.01% |
91,590
+180
| +0.2% | +$3.79K |
|
2303
International Bancshares
IBOC
$4.74B
| $1.94M | ﹤0.01% |
65,250
| – | – |
|
|
PCOM
2304
DELISTED
Points.com Inc. Common Shares
PCOM
| $1.93M | ﹤0.01% |
215,981
+12,300
| +6% | +$106K |
|
|
GAP
2305
The Gap Inc
GAP
$7.38B
| $1.9M | ﹤0.01% |
85,386
-126,245
| -60% | -$3.05M |
|
2306
Adtran
ADTN
$718M
| $1.9M | ﹤0.01% |
98,996
-8,695
| -8% | -$160K |
|
|
SYBX
2307
DELISTED
Synlogic
SYBX
| $1.89M | ﹤0.01% |
9,142
-3,624
| -28% | -$1.27M |
|
|
FCSC
2308
DELISTED
Fibrocell Science Inc.
FCSC
| $1.88M | ﹤0.01% |
173,763
| – | – |
|
2309
Viavi Solutions
VIAV
$9.95B
| $1.87M | ﹤0.01% |
253,370
+27,970
| +12% | +$205K |
|
|
XXIA
2310
DELISTED
Ixia
XXIA
| $1.85M | ﹤0.01% |
148,430
-265,658
| -64% | -$3.04M |
|
|
NSM
2311
DELISTED
Nationstar Mortgage Holdings
NSM
| $1.81M | ﹤0.01% |
122,395
| – | – |
|
|
SVT
2312
DELISTED
Servotronics
SVT
| $1.81M | ﹤0.01% |
163,256
| – | – |
|
2313
Intrepid Potash
IPI
$456M
| $1.81M | ﹤0.01% |
160,260
-2,680
| -2% | -$35.1K |
|
|
CTIC
2314
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.8M | ﹤0.01% |
480,000
-664,526
| -58% | -$2.42M |
|
|
INFI
2315
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.79M | ﹤0.01% |
1,146,500
+60,000
| +6% | +$92.2K |
|
2316
Pitney Bowes
PBI
$2.48B
| $1.77M | ﹤0.01% |
97,692
-6,198
| -6% | -$114K |
|
|
LTRPA
2317
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.77M | ﹤0.01% |
80,942
-7,766
| -9% | -$170K |
|
2318
Quantum Corp
QMCO
$451M
| $1.76M | ﹤0.01% |
14,982
+40
| +0.3% | +$3.91K |
|
|
CPLA
2319
DELISTED
Capella Education Company
CPLA
| $1.76M | ﹤0.01% |
30,400
+100
| +0.3% | +$5.83K |
|
2320
Horizon Bancorp
HBNC
$1.06B
| $1.76M | ﹤0.01% |
135,000
| – | – |
|
|
RBCN
2321
DELISTED
Rubicon Technology, Inc.
RBCN
| $1.73M | ﹤0.01% |
273,887
+1,346
| +0.5% | +$8.59K |
|
2322
IAMGOLD
IAG
$8.55B
| $1.7M | ﹤0.01% |
421,550
-217,100
| -34% | -$990K |
|
2323
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
| $1.7M | ﹤0.01% |
25,616
-1,488
| -5% | -$98.3K |
|
|
BLPH
2324
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $1.69M | ﹤0.01% |
80,538
| – | – |
|
2325
Myriad Genetics
MYGN
$289M
| $1.69M | ﹤0.01% |
82,118
-815,882
| -91% | -$20.7M |
|
Similar funds
Fidelity Investments's Q3 2016 Portfolio in Review
As of Q3 2016, Fidelity Investments held 2,796 positions worth $751B, up 2.5% from $733B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Fidelity Investments withdrew a net $22.6B in Q3 2016, closing 150 positions and reducing 1,143 holdings. Its most notable exit was EMC CORPORATION, an estimated $1.56B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Fidelity Investments opened a new position in Fortive worth $1.26B.
- Fidelity Investments's largest Q3 2016 buy was Fortive: 39,374,472 shares worth $1.26B.
- Fidelity Investments added most to Apple in Q3 2016, an estimated $2.75B increase.
- Fidelity Investments's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $1.98B.
- Fidelity Investments fully exited EMC CORPORATION in Q3 2016, selling an estimated $1.56B.
- Fidelity Investments's ten largest holdings make up 16% of its $751B portfolio in Q3 2016.
- Fidelity Investments opened 147 new positions and closed 150 in Q3 2016.
- Fidelity Investments's portfolio value rose 2.5% quarter-over-quarter to $751B.
Based on Fidelity Investments's 13F filing for Q3 2016, filed 14 Nov 2016.